Skip to content

Drug interactions

Apalutamide + Rivaroxaban

Severity: Major

Apalutamide and Rivaroxaban: major interaction.

Last updated Sources: US FDA label

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Apalutamide is a strong inducer of CYP3A4 and P-gp and can markedly lower rivaroxaban exposure. This may lead to loss of anticoagulant protection and thrombotic events such as stroke or venous thromboembolism.

What this interaction means in plain words

Apalutamide and Rivaroxaban can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Apalutamide belongs to Endocrine; Rivaroxaban belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Induction of CYP3A4 and P-glycoprotein increases rivaroxaban clearance.

What to do

Avoid the combination where possible and consider an alternative anticoagulant not dependent on these pathways. If unavoidable, monitor closely for thromboembolic events.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Apalutamide and Rivaroxaban, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Apalutamide with Rivaroxaban?

MediHelp rates the interaction as major. Apalutamide and Rivaroxaban can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Apalutamide is a strong inducer of CYP3A4 and P-gp and can markedly lower rivaroxaban exposure. This may lead to loss of anticoagulant protection and thrombotic events such as stroke or venous thromboembolism.

How serious is the interaction between Apalutamide and Rivaroxaban?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where possible and consider an alternative anticoagulant not dependent on these pathways. If unavoidable, monitor closely for thromboembolic events.

What other medicines interact with Rivaroxaban?

MediHelp also lists interactions of Rivaroxaban with, for example, Defibrotide, Ketoconazole, Ketorolac. The full list is on the Rivaroxaban page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in